Glioblastoma




GBM Treatment Market expected to rise 5x to $3.3 billion by 2024, across the major markets of the US, Europe, and Japan, primarily due to the launch of new therapies (Global Data)

Aurora is researching Bispecfic CAR T Cell Therapy targeting HER2 and GD2 against Glioblastoma.